The human microbiome in rheumatic autoimmune diseases: A comprehensive review

Clinical Immunology

Volumn 170, Issue , 2016, Pages 70-79

  Coit, Patrick ^a   Sawalha, Amr H ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Autoimmunity; Dysbiosis; Metagenomics; Microbiome; Rheumatic diseases; Rheumatology

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RNA 16S;

ACIDAMINOCOCCACEAE; ACTINOBACTERIA; ANKYLOSING SPONDYLITIS; BACTEROIDES; BACTEROIDETES; BEHCET DISEASE; BIFIDOBACTERIUM; BLAUTIA; CANDIDA; DISEASE PREDISPOSITION; DYSBIOSIS; FAECALIBACTERIUM; FIRMICUTES; FUSOBACTERIUM; GENETIC RISK; GIANT CELL ARTERITIS; HAEMOPHILUS; HIGH THROUGHPUT SEQUENCING; HUMAN; INTESTINE FLORA; LACHNOSPIRACEAE; LACTOBACILLUS; LEPTOTRICHIA; MICROBIAL DIVERSITY; MICROBIOME; MUCOCUTANEOUS LYMPH NODE SYNDROME; NONHUMAN; PARABACTEROIDES; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; PREVOTELLA; PREVOTELLACEAE; PRIORITY JOURNAL; PROPIONIBACTERIUM; PSORIATIC ARTHRITIS; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; ROTHIA; RUMINOCOCCACEAE; RUMINOCOCCUS; SHIGELLA; SJOEGREN SYNDROME; STREPTOCOCCUS; SYSTEMIC LUPUS ERYTHEMATOSUS; TANNERELLA FORSYTHIA; TREPONEMA DENTICOLA; VASCULITIS; VEILLONELLA; AUTOIMMUNE DISEASE; BACTERIUM; CLASSIFICATION; DNA SEQUENCE; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY; POPULATION DYNAMICS;

AUTOIMMUNE DISEASES; BACTERIA; DYSBIOSIS; HOST-PATHOGEN INTERACTIONS; HUMANS; MICROBIOTA; POPULATION DYNAMICS; RHEUMATIC DISEASES; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA;

EID: 84981250455     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2016.07.026     Document Type: Review

References (115)

1. [1] Ursell, L.K., Metcalf, J.L., Parfrey, L.W., Knight, R., Defining the human microbiome. Nutr. Rev. 70 (2012), S38–S44.
2. [2] Hiergeist, A., Gläsner, J., Reischl, U., Gessner, A., Analyses of intestinal microbiota: culture versus sequencing. ILAR J. 56 (2015), 228–240.
3. [3] Schloss, P.D., Westcott, S.L., Ryabin, T., Hall, J.R., Hartmann, M., Hollister, E.B., Lesniewski, R.A., Oakley, B.B., Parks, D.H., Robinson, C.J., Sahl, J.W., Stres, B., Thallinger, G.G., Van Horn, D.J., Weber, C.F., Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75 (2009), 7537–7541.
4. [4] Caporaso, J.G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F.D., Costello, E.K., Fierer, N., Pena, A.G., Goodrich, J.K., Gordon, J.I., QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7 (2010), 335–336.
5. [5] Goodrich, J.K., Di Rienzi, S.C., Poole, A.C., Koren, O., Walters, W.A., Caporaso, J.G., Knight, R., Ley, R.E., Conducting a microbiome study. Cell 158 (2014), 250–262.
6. [6] Sharpton, T.J., An introduction to the analysis of shotgun metagenomic data. Front. Plant Sci., 5, 2014, 209.
7. [7] Wang, W.-L., Xu, S.-Y., Ren, Z.-G., Tao, L., Jiang, J.-W., Zheng, S.-S., Application of metagenomics in the human gut microbiome. World J. Gastroenterol. 21 (2015), 803–814.
8. [8] Yassour, M., Lim, M.Y., Yun, H.S., Tickle, T.L., Sung, J., Song, Y.-M., Lee, K., Franzosa, E.A., Morgan, X.C., Gevers, D., Lander, E.S., Xavier, R.J., Birren, B.W., Ko, G., Huttenhower, C., Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes. Genome Med., 8, 2016, 17.
9. [9] Bennike, T., Birkelund, S., Stensballe, A., Andersen, V., Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies. World J. Gastroenterol. 20 (2014), 3231–3244.
10. [10] Yang, F., Zeng, X., Ning, K., Liu, K.-L., Lo, C.-C., Wang, W., Chen, J., Wang, D., Huang, R., Chang, X., Chain, P.S., Xie, G., Ling, J., Xu, J., Saliva microbiomes distinguish caries-active from healthy human populations. ISME J. 6 (2012), 1–10.
11. [11] Blekhman, R., Goodrich, J.K., Huang, K., Sun, Q., Bukowski, R., Bell, J.T., Spector, T.D., Keinan, A., Ley, R.E., Gevers, D., Clark, A.G., Host genetic variation impacts microbiome composition across human body sites. Genome Biol., 16, 2015, 191.
12. [12] Wacklin, P., Tuimala, J., Nikkilä, J., Sebastian, T., Mäkivuokko, H., Alakulppi, N., Laine, P., Rajilic-Stojanovic, M., Paulin, L., de Vos, W.M., Mättö, J., Faecal microbiota composition in adults is associated with the FUT2 gene determining the secretor status. PLoS One, 9, 2014, e94863.
13. [13] Gomez, A., Luckey, D., Taneja, V., The gut microbiome in autoimmunity: sex matters. Clin. Immunol. 159 (2015), 154–162 Orlando, Fla.
14. [14] David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., Ling, A.V., Devlin, A.S., Varma, Y., Fischbach, M.A., Biddinger, S.B., Dutton, R.J., Turnbaugh, P.J., Diet rapidly and reproducibly alters the human gut microbiome. Nature 505 (2014), 559–563.
15. [15] Takahashi, K., Influence of bacteria on epigenetic gene control. Cell. Mol. Life Sci. 71 (2014), 1045–1054.
16. [16] Cho, I., Blaser, M.J., The human microbiome: at the interface of health and disease. Nat. Rev. Genet. 13 (2012), 260–270.
17. [17] Dethlefsen, L., Huse, S., Sogin, M.L., Relman, D.A., The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol., 6, 2008, e280.
18. [18] Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K.S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., Yamada, T., Mende, D.R., Li, J., Xu, J., Li, S., Li, D., Cao, J., Wang, B., Liang, H., Zheng, H., Xie, Y., Tap, J., Lepage, P., Bertalan, M., Batto, J.-M., Hansen, T., Le Paslier, D., Linneberg, A., Nielsen, H.B., Pelletier, E., Renault, P., Sicheritz-Ponten, T., Turner, K., Zhu, H., Yu, C., Li, S., Jian, M., Zhou, Y., Li, Y., Zhang, X., Li, S., Qin, N., Yang, H., Wang, J., Brunak, S., Dore, J., Guarner, F., Kristiansen, K., Pedersen, O., Parkhill, J., Weissenbach, J., Bork, P., Ehrlich, S.D., Wang, J., A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464 (2010), 59–65.
19. [19] Lozupone, C.A., Stombaugh, J.I., Gordon, J.I., Jansson, J.K., Knight, R., Diversity, stability and resilience of the human gut microbiota. Nature 489 (2012), 220–230.
20. [20] Turnbaugh, P.J., Ley, R.E., Hamady, M., Fraser-Liggett, C., Knight, R., Gordon, J.I., The human microbiome project: exploring the microbial part of ourselves in a changing world. Nature 449 (2007), 804–810.
21. [21] Gill, S.R., Pop, M., Deboy, R.T., Eckburg, P.B., Turnbaugh, P.J., Samuel, B.S., Gordon, J.I., Relman, D.A., Fraser-Liggett, C.M., Nelson, K.E., Metagenomic analysis of the human distal gut microbiome. Science 312 (2006), 1355–1359.
22. [22] Round, J.L., Mazmanian, S.K., The gut microbiome shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9 (2009), 313–323.
23. [23] Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D.R., Fernandes, G.R., Tap, J., Bruls, T., Batto, J.-M., Bertalan, M., Borruel, N., Casellas, F., Fernandez, L., Gautier, L., Hansen, T., Hattori, M., Hayashi, T., Kleerebezem, M., Kurokawa, K., Leclerc, M., Levenez, F., Manichanh, C., Nielsen, H.B., Nielsen, T., Pons, N., Poulain, J., Qin, J., Sicheritz-Ponten, T., Tims, S., Torrents, D., Ugarte, E., Zoetendal, E.G., Wang, J., Guarner, F., Pedersen, O., de Vos, W.M., Brunak, S., Dore, J., Weissenbach, J., Ehrlich, S.D., Bork, P., Enterotypes of the human gut microbiome. Nature 473 (2011), 174–180.
24. [24] Abdollahi-Roodsaz, S., Abramson, S.B., Scher, J.U., The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions. Nat. Rev. Rheumatol., 2016.
25. [25] Smith, P.M., Howitt, M.R., Panikov, N., Michaud, M., Gallini, C.A., Bohlooly-Y, M., Glickman, J.N., Garrett, W.S., The microbial metabolites, short chain fatty acids, regulate colonic Treg cell homeostasis. Science (New York, N.Y.), 341, 2013, 10.1126/science.1241165.
26. [26] Ghannoum, M.A., Jurevic, R.J., Mukherjee, P.K., Cui, F., Sikaroodi, M., Naqvi, A., Gillevet, P.M., Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog., 6, 2010, e1000713.
27. [27] Cui, L., Morris, A., Ghedin, E., The human mycobiome in health and disease. Genome Med. 5 (2013), 1–12.
28. [28] Delwart, E., A roadmap to the human virome. PLoS Pathog., 9, 2013, e1003146.
29. [29] McInnes, I.B., Schett, G., The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365 (2011), 2205–2219.
30. [30] Choy, E., Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology 51 (2012), v3–v11.
31. [31] Terao, C., Raychaudhuri, S., Gregersen, P.K., Recent advances in defining the genetic basis of rheumatoid arthritis. Annu. Rev. Genomics Hum. Genet., 17, 2016 null.
32. [32] de Pablo, P., Chapple, I.L.C., Buckley, C.D., Dietrich, T., Periodontitis in systemic rheumatic diseases. Nat. Rev. Rheumatol., 5, 2009, 218 +.
33. [33] Fuggle, N.R., Smith, T.O., Kaul, A., Sofat, N., Hand to mouth: a systematic review and meta-analysis of the association between rheumatoid arthritis and periodontitis. Front. Immunol., 7, 2016, 80.
34. [34] Mikuls, T.R., Payne, J.B., Yu, F., Thiele, G.M., Reynolds, R.J., Cannon, G.W., Markt, J., McGowan, D., Kerr, G.S., Redman, R.S., Reimold, A., Griffiths, G., Beatty, M., Gonzalez, S.M., Bergman, D.A., Hamilton, B.C. 3rd, Erickson, A.R., Sokolove, J., Robinson, W.H., Walker, C., Chandad, F., O'Dell, J.R., Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis Rheumatol. 66 (2014), 1090–1100.
35. [35] Socransky, S.S., Haffajee, A.D., Cugini, M.A., Smith, C., Kent, R.L., Microbial complexes in subgingival plaque. J. Clin. Periodontol. 25 (1998), 134–144.
36. [36] Mikuls, T.R., Thiele, G.M., Deane, K.D., Payne, J.B., O'Dell, J.R., Yu, F., Sayles, H., Weisman, M.H., Gregersen, P.K., Buckner, J.H., Keating, R.M., Derber, L.A., Robinson, W.H., Holers, V.M., Norris, J.M., Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis. Arthritis Rheum. 64 (2012), 3522–3530.
37. [37] Scher, J.U., Ubeda, C., Equinda, M., Khanin, R., Buischi, Y., Viale, A., Lipuma, L., Attur, M., Pillinger, M.H., Weissmann, G., Littman, D.R., Pamer, E.G., Bretz, W.A., Abramson, S.B., Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum. 64 (2012), 3083–3094.
38. [38] Scher, J.U., Bretz, W.A., Abramson, S.B., Periodontal disease and subgingival microbiota as contributors for rheumatoid arthritis pathogenesis: modifiable risk factors?. Curr. Opin. Rheumatol. 26 (2014), 424–429.
39. [39] Ortiz, P., Bissada, N.F., Palomo, L., Han, Y.W., Al-Zahrani, M.S., Panneerselvam, A., Askari, A., Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. J. Periodontol. 80 (2009), 535–540.
40. [40] Erciyas, K., Sezer, U., Ustun, K., Pehlivan, Y., Kisacik, B., Senyurt, S.Z., Tarakcioglu, M., Onat, A.M., Effects of periodontal therapy on disease activity and systemic inflammation in rheumatoid arthritis patients. Oral Dis. 19 (2013), 394–400.
41. [41] Al-Katma, M.K., Bissada, N.F., Bordeaux, J.M., Sue, J., Askari, A.D., Control of periodontal infection reduces the severity of active rheumatoid arthritis. J. Clin. Rheumatol. 13 (2007), 134–137.
42. [42] Scher, J.U., Abramson, S.B., The microbiome and rheumatoid arthritis. Nat. Rev. Rheumatol. 7 (2011), 569–578.
43. [43] Liu, X., Zou, Q., Zeng, B., Fang, Y., Wei, H., Analysis of fecal Lactobacillus community structure in patients with early rheumatoid arthritis. Curr. Microbiol. 67 (2013), 170–176.
44. [44] Alipour, B., Homayouni-Rad, A., Vaghef-Mehrabany, E., Sharif, S.K., Vaghef-Mehrabany, L., Asghari-Jafarabadi, M., Nakhjavani, M.R., Mohtadi-Nia, J., Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double-blind clinical trial. Int. J. Rheum. Dis. 17 (2014), 519–527.
45. [45] Vaghef-Mehrabany, E., Alipour, B., Homayouni-Rad, A., Sharif, S.K., Asghari-Jafarabadi, M., Zavvari, S., Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis. Nutrition 30 (2014), 430–435 Burbank, Los Angeles County, Calif.
46. [46] Chappert, P., Role of SFB in autoimmune arthritis: an example of regulation of autoreactive T cell sensitivity in the gut. Gut Microbes 5 (2014), 259–264.
47. [47] Chappert, P., Bouladoux, N., Naik, S., Schwartz, R.H., Specific gut commensal flora locally alters T cell tuning to endogenous ligands. Immunity 38 (2013), 1198–1210.
48. [48] Scher, J.U., Sczesnak, A., Longman, R.S., Segata, N., Ubeda, C., Bielski, C., Rostron, T., Cerundolo, V., Pamer, E.G., Abramson, S.B., Huttenhower, C., Littman, D.R., Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. eLife, 2, 2013, e01202.
49. [49] Maeda, Y., Kurakawa, T., Umemoto, E., Motooka, D., Ito, Y., Gotoh, K., Hirota, K., Matsushita, M., Furuta, Y., Narazaki, M., Sakaguchi, N., Kayama, H., Nakamura, S., Iida, T., Saeki, Y., Kumanogoh, A., Sakaguchi, S., Takeda, K., Dysbiosis contributes to arthritis development via activation of autoreactive T cells in the intestine. Arthritis Rheumatol., 2016.
50. [50] Zhang, X., Zhang, D., Jia, H., Feng, Q., Wang, D., Liang, D., Wu, X., Li, J., Tang, L., Li, Y., Lan, Z., Chen, B., Li, Y., Zhong, H., Xie, H., Jie, Z., Chen, W., Tang, S., Xu, X., Wang, X., Cai, X., Liu, S., Xia, Y., Li, J., Qiao, X., Al-Aama, J.Y., Chen, H., Wang, L., Wu, Q.J., Zhang, F., Zheng, W., Li, Y., Zhang, M., Luo, G., Xue, W., Xiao, L., Li, J., Chen, W., Xu, X., Yin, Y., Yang, H., Wang, J., Kristiansen, K., Liu, L., Li, T., Huang, Q., Li, Y., Wang, J., The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat. Med. 21 (2015), 895–905.
51. [51] Sieper, J., Braun, J., Rudwaleit, M., Boonen, A., Zink, A., Ankylosing spondylitis: an overview. Ann. Rheum. Dis. 61 (2002), iii8–iii18.
52. [52] Dean, L.E., Jones, G.T., MacDonald, A.G., Downham, C., Sturrock, R.D., Macfarlane, G.J., Global prevalence of ankylosing spondylitis. Rheumatology (Oxford) 53 (2014), 650–657.
53. [53] Robinson, P.C., Brown, M.A., Genetics of ankylosing spondylitis. Mol. Immunol. 57 (2014), 2–11.
54. [54] Rosenbaum, J.T., Davey, M.P., Time for a gut check: evidence for the hypothesis that HLA-B27 predisposes to ankylosing spondylitis by altering the microbiome. Arthritis Rheum. 63 (2011), 3195–3198.
55. [55] The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp. Med., 1994, 2359–2364.
56. [56] Rosenbaum, J.T., Lin, P., Asquith, M., Costello, M.E., Kenna, T.J., Brown, M.A., Does the microbiome play a causal role in spondyloarthritis?. Clin. Rheumatol. 33 (2014), 763–767.
57. [57] Stebbings, S., Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis. Rheumatology 41 (2002), 1395–1401.
58. [58] Costello, M.E., Ciccia, F., Willner, D., Warrington, N., Robinson, P.C., Gardiner, B., Marshall, M., Kenna, T.J., Triolo, G., Brown, M.A., Intestinal dysbiosis in ankylosing spondylitis. Arthritis Rheumatol., 2014.
59. [59] Stoll, M.L., Kumar, R., Morrow, C.D., Lefkowitz, E.J., Cui, X., Genin, A., Cron, R.Q., Elson, C.O., Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis. Arthritis Res. Ther., 16, 2014, 486.
60. [60] Sinkorova, Z., Capkova, J., Niederlova, J., Stepankova, R., Sinkora, J., Commensal intestinal bacterial strains trigger ankylosing enthesopathy of the ankle in inbred B10.BR (H-2(k)) male mice. Hum. Immunol. 69 (2008), 845–850.
61. [61] Rath, H.C., Herfarth, H.H., Ikeda, J.S., Grenther, W.B., Hamm, T.E. Jr., Balish, E., Taurog, J.D., Hammer, R.E., Wilson, K.H., Sartor, R.B., Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J. Clin. Invest. 98 (1996), 945–953.
62. [62] Cantini, F., Niccoli, L., Nannini, C., Kaloudi, O., Bertoni, M., CassarÀ, E., Psoriatic arthritis: a systematic review. Int. J. Rheum. Dis. 13 (2010), 300–317.
63. [63] Rahman, P., Elder, J.T., Genetic epidemiology of psoriasis and psoriatic arthritis. Ann. Rheum. Dis. 64 (2005), ii37–ii39.
64. [64] Li, W.Q., Han, J.L., Chan, A.T., Qureshi, A.A., Psoriasis, psoriatic arthritis and increased risk of incident Crohn's disease in US women. Ann. Rheum. Dis. 72 (2013), 1200–1205.
65. [65] Skroza, N., Proietti, I., Pampena, R., La Viola, G., Bernardini, N., Nicolucci, F., Tolino, E., Zuber, S., Soccodato, V., Potenza, C., Correlations between psoriasis and inflammatory bowel diseases. Biomed Res. Int., 2013, 2013, 983902.
66. [66] Kostic, A.D., Xavier, R.J., Gevers, D., The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 146 (2014), 1489–1499.
67. [67] Scher, J.U., Ubeda, C., Artacho, A., Attur, M., Isaac, S., Reddy, S.M., Marmon, S., Neimann, A., Brusca, S., Patel, T., Manasson, J., Pamer, E.G., Littman, D.R., Abramson, S.B., Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol. 67 (2015), 128–139.
68. [68] Gao, Z., Tseng, C.H., Strober, B.E., Pei, Z., Blaser, M.J., Substantial alterations of the cutaneous bacterial biota in psoriatic lesions. PLoS One, 3, 2008, e2719.
69. [69] Agak, G.W., Qin, M., Nobe, J., Kim, M.H., Krutzik, S.R., Tristan, G.R., Elashoff, D., Garban, H.J., Kim, J., Propionibacterium acnes induces an IL-17 response in acne vulgaris that is regulated by vitamin A and vitamin D. J. Investig. Dermatol. 134 (2014), 366–373.
70. [70] Kelhala, H.L., Palatsi, R., Fyhrquist, N., Lehtimaki, S., Vayrynen, J.P., Kallioinen, M., Kubin, M.E., Greco, D., Tasanen, K., Alenius, H., Bertino, B., Carlavan, I., Mehul, B., Deret, S., Reiniche, P., Martel, P., Marty, C., Blume-Peytavi, U., Voegel, J.J., Lauerma, A., IL-17/Th17 pathway is activated in acne lesions. PLoS One, 9, 2014, e105238.
71. [71] Kistowska, M., Meier, B., Proust, T., Feldmeyer, L., Cozzio, A., Kuendig, T., Contassot, E., French, L.E., Propionibacterium acnes promotes Th17 and Th17/Th1 responses in acne patients. J. Investig. Dermatol. 135 (2015), 110–118.
72. [72] Castelino, M., Eyre, S., Upton, M., Ho, P., Barton, A., The bacterial skin microbiome in psoriatic arthritis, an unexplored link in pathogenesis: challenges and opportunities offered by recent technological advances. Rheumatology (Oxford) 53 (2014), 777–784.
73. [73] Tsokos, G.C., Systemic lupus erythematosus. N. Engl. J. Med. 365 (2011), 2110–2121.
74. [74] Bentham, J., Morris, D.L., Cunninghame Graham, D.S., Pinder, C.L., Tombleson, P., Behrens, T.W., Martin, J., Fairfax, B.P., Knight, J.C., Chen, L., Replogle, J., Syvanen, A.C., Ronnblom, L., Graham, R.R., Wither, J.E., Rioux, J.D., Alarcon-Riquelme, M.E., Vyse, T.J., Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat. Genet. 47 (2015), 1457–1464.
75. [75] Hevia, A., Milani, C., Lopez, P., Cuervo, A., Arboleya, S., Duranti, S., Turroni, F., Gonzalez, S., Suarez, A., Gueimonde, M., Ventura, M., Sanchez, B., Margolles, A., Intestinal dysbiosis associated with systemic lupus erythematosus. MBio, 5, 2014 e01548-01514.
76. [76] Lopez, P., de Paz, B., Rodriguez-Carrio, J., Hevia, A., Sanchez, B., Margolles, A., Suarez, A., Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients. Sci. Rep., 6, 2016, 24072.
77. [77] Rahman, M., Sing, S., Golabkesh, Z., Fiskesund, R., Gustafsson, T., Jogestrand, T., Frostegard, A.G., Hafstrom, I., Liu, A., Frostegard, J., IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: regulation and underlying mechanisms. Clin. Immunol. 166–167 (2016), 27–37.
78. [78] Gronwall, C., Reynolds, H., Kim, J.K., Buyon, J., Goldberg, J.D., Clancy, R.M., Silverman, G.J., Relation of carotid plaque with natural IgM antibodies in patients with systemic lupus erythematosus. Clin. Immunol. 153 (2014), 1–7.
79. [79] Cuervo, A., Hevia, A., Lopez, P., Suarez, A., Sanchez, B., Margolles, A., Gonzalez, S., Association of polyphenols from oranges and apples with specific intestinal microorganisms in systemic lupus erythematosus patients. Nutrients 7 (2015), 1301–1317.
80. [80] Bayetto, K., Logan, R.M., Sjögren's syndrome: a review of aetiology, pathogenesis, diagnosis and management. Aust. Dent. J. 55 (2010), 39–47.
81. [81] Patel, R., Shahane, A., The epidemiology of Sjogren's syndrome. Clin. Epidemiol. 6 (2014), 247–255.
82. [82] Pedersen, A.M.L., Bardow, A., Nauntofte, B., Salivary changes and dental caries as potential oral markers of autoimmune salivary gland dysfunction in primary Sjögren's syndrome. BMC Clin. Pathol. 5 (2005), 1–13.
83. [83] Almstah, I.A., Wikstrom, M., Stenberg, I., Jakobsson, A., Fagerberg-Mohlin, B., Oral microbiota associated with hyposalivation of different origins. Oral Microbiol. Immunol. 18 (2003), 1–8.
84. [84] Berkowitz, R.J., Mutans streptococci: acquisition and transmission. Pediatr. Dent. 28 (2006), 106–109 discussion 192–108.
85. [85] Leung, K.C., Leung, W.K., McMillan, A.S., Supra-gingival microbiota in Sjogren's syndrome. Clin. Oral Investig. 11 (2007), 415–423.
86. [86] Li, M., Zou, Y., Jiang, Q., Jiang, L., Yu, Q., Ding, X., Yu, Y., A preliminary study of the oral microbiota in Chinese patients with Sjögren's syndrome. Arch. Oral Biol. 70 (2016), 143–148.
87. [87] de Paiva, C.S., Jones, D.B., Stern, M.E., Bian, F., Moore, Q.L., Corbiere, S., Streckfus, C.F., Hutchinson, D.S., Ajami, N.J., Petrosino, J.F., Pflugfelder, S.C., Altered mucosal microbiome diversity and disease severity in Sjögren syndrome. Sci. Rep., 6, 2016, 23561.
88. [88] Waugh, J.B., Granger, W.M., Gaggar, A., Incidence, relevance and response for Ralstonia respiratory infections. Clin. Lab. Sci. 23 (2010), 99–106.
89. [89] Cusick, M.F., Libbey, J.E., Fujinami, R.S., Molecular mimicry as a mechanism of autoimmune disease. Clin. Rev. Allergy Immunol. 42 (2012), 102–111.
90. [90] Szymula, A., Rosenthal, J., Szczerba, B.M., Bagavant, H., Fu, S.M., Deshmukh, U.S., T cell epitope mimicry between Sjogren's syndrome Antigen A (SSA)/Ro60 and oral, gut, skin and vaginal bacteria. Clin. Immunol. 152 (2014), 1–9 Orlando, Fla.
91. [91] Jennette, J.C., Falk, R.J., Bacon, P.A., Basu, N., Cid, M.C., Ferrario, F., Flores-Suarez, L.F., Gross, W.L., Guillevin, L., Hagen, E.C., Hoffman, G.S., Jayne, D.R., Kallenberg, C.G.M., Lamprecht, P., Langford, C.A., Luqmani, R.A., Mahr, A.D., Matteson, E.L., Merkel, P.A., Ozen, S., Pusey, C.D., Rasmussen, N., Rees, A.J., Scott, D.G.I., Specks, U., Stone, J.H., Takahashi, K., Watts, R.A., 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 65 (2013), 1–11.
92. [92] Clifford, A., Hoffman, G.S., Evidence for a vascular microbiome and its role in vessel health and disease. Curr. Opin. Rheumatol. 27 (2015), 397–405.
93. [93] Muñoz-Grajales, C., Pineda, J.C., Pathophysiological relationship between infections and systemic vasculitis. Autoimmune Dis., 2015, 2015.
94. [94] Davatchi, F., Chams-Davatchi, C., Shams, H., Shahram, F., Nadji, A., Akhlaghi, M., Faezi, T., Ghodsi, Z., Sadeghi Abdollahi, B., Ashofteh, F., Mohtasham, N., Kavosi, H., Masoumi, M., Behcet's disease: epidemiology, clinical manifestations, and diagnosis. Expert. Rev. Clin. Immunol., 2016, 1–9.
95. [95] Seoudi, N., Bergmeier, L.A., Drobniewski, F., Paster, B., Fortune, F., The oral mucosal and salivary microbial community of Behcet's syndrome and recurrent aphthous stomatitis. J. Oral Microbiol., 7, 2015, 27150.
96. [96] Coit, P., Mumcu, G., Ture-Ozdemir, F., Unal, A.U., Alpar, U., Bostanci, N., Ergun, T., Direskeneli, H., Sawalha, A.H., Sequencing of 16S rRNA reveals a distinct salivary microbiome signature in Behçet's disease. Clin. Immunol., 2016.
97. [97] Hughes, T., Coit, P., Adler, A., Yilmaz, V., Aksu, K., Duzgun, N., Keser, G., Cefle, A., Yazici, A., Ergen, A., Alpsoy, E., Salvarani, C., Casali, B., Kotter, I., Gutierrez-Achury, J., Wijmenga, C., Direskeneli, H., Saruhan-Direskeneli, G., Sawalha, A.H., Identification of multiple independent susceptibility loci in the HLA region in Behcet's disease. Nat. Genet. 45 (2013), 319–324.
98. [98] Consolandi, C., Turroni, S., Emmi, G., Severgnini, M., Fiori, J., Peano, C., Biagi, E., Grassi, A., Rampelli, S., Silvestri, E., Centanni, M., Cianchi, F., Gotti, R., Emmi, L., Brigidi, P., Bizzaro, N., De Bellis, G., Prisco, D., Candela, M., D'Elios, M.M., Behcet's syndrome patients exhibit specific microbiome signature. Autoimmun. Rev. 14 (2015), 269–276.
99. [99] Shimizu, J., Kubota, T., Takada, E., Takai, K., Fujiwara, N., Arimitsu, N., Ueda, Y., Wakisaka, S., Suzuki, T., Suzuki, N., Bifidobacteria abundance-featured gut microbiota compositional change in patients with Behcet's disease. PLoS One, 11, 2016, e0153746.
100. [100] Kale, N., Eggenberger, E., Diagnosis and management of giant cell arteritis: a review. Curr. Opin. Ophthalmol. 21 (2010), 417–422.
101. [101] Bhatt, A.S., Manzo, V.E., Pedamallu, C.S., Duke, F., Cai, D., Bienfang, D.C., Padera, R.F., Meyerson, M., Docken, W.P., In search of a candidate pathogen for giant cell arteritis: sequencing-based characterization of the giant cell arteritis microbiome. Arthritis Rheumatol. 66 (2014), 1939–1944.
102. [102] Kinumaki, A., Sekizuka, T., Hamada, H., Kato, K., Yamashita, A., Kuroda, M., Characterization of the gut microbiota of Kawasaki disease patients by metagenomic analysis. Front. Microbiol., 6, 2015, 824.
103. [103] Kassam, Z., Lee, C.H., Yuan, Y., Hunt, R.H., Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am. J. Gastroenterol. 108 (2013), 500–508.
104. [104] Pozhitkov, A.E., Leroux, B.G., Randolph, T.W., Beikler, T., Flemmig, T.F., Noble, P.A., Towards microbiome transplant as a therapy for periodontitis: an exploratory study of periodontitis microbial signature contrasted by oral health, caries and edentulism. BMC Oral Health 15 (2015), 1–11.
105. [105] Scott, K.P., Antoine, J.-M., Midtvedt, T., van Hemert, S., Manipulating the gut microbiota to maintain health and treat disease. Microb. Ecol. Health Dis., 26, 2015, 10.3402/mehd.v3426.25877.
106. [106] Hemarajata, P., Versalovic, J., Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Ther. Adv. Gastroenterol. 6 (2013), 39–51.
107. [107] Wang, J., Jia, H., Metagenome-wide association studies: fine-mining the microbiome. Nat. Rev. Microbiol. 14 (2016), 508–522.
108. [108] Klareskog, L., Stolt, P., Lundberg, K., Källberg, H., Bengtsson, C., Grunewald, J., Rönnelid, J., Erlandsson Harris, H., Ulfgren, A.-K., Rantapää-Dahlqvist, S., Eklund, A., Padyukov, L., Alfredsson, L., A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA–DR (shared epitope)–restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 54 (2006), 38–46.
109. [109] Kharlamova, N., Jiang, X., Sherina, N., Potempa, B., Israelsson, L., Quirke, A.-M., Eriksson, K., Yucel-Lindberg, T., Venables, P.J., Potempa, J., Alfredsson, L., Lundberg, K., Antibodies to Porphyromonas gingivalis indicate interaction between oral infection, smoking, and risk genes in rheumatoid arthritis etiology. Arthritis Rheumatol. 68 (2016), 604–613.
110. [110] Srinivas, G., Möller, S., Wang, J., Künzel, S., Zillikens, D., Baines, J.F., Ibrahim, S.M., Genome-wide mapping of gene–microbiota interactions in susceptibility to autoimmune skin blistering. Nat. Commun., 4, 2013.
111. [111] Benson, A.K., Kelly, S.A., Legge, R., Ma, F., Low, S.J., Kim, J., Zhang, M., Oh, P.L., Nehrenberg, D., Hua, K., Kachman, S.D., Moriyama, E.N., Walter, J., Peterson, D.A., Pomp, D., Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors. Proc. Natl. Acad. Sci. 107 (2010), 18933–18938.
112. [112] McKnite, A.M., Perez-Munoz, M.E., Lu, L., Williams, E.G., Brewer, S., Andreux, P.A., Bastiaansen, J.W.M., Wang, X., Kachman, S.D., Auwerx, J., Williams, R.W., Benson, A.K., Peterson, D.A., Ciobanu, D.C., Murine gut microbiota is defined by host genetics and modulates variation of metabolic traits. PLoS One, 7, 2012, e39191.
113. [113] Leamy, L.J., Kelly, S.A., Hua, K., Pomp, D., Exercise and diet affect quantitative trait loci for body weight and composition traits in an advanced intercross population of mice. Physiol. Genomics, 44, 2012.
114. [114] Leamy, L.J., Kelly, S.A., Nietfeldt, J., Legge, R.M., Ma, F., Hua, K., Sinha, R., Peterson, D.A., Walter, J., Benson, A.K., Pomp, D., Host genetics and diet, but not immunoglobulin A expression, converge to shape compositional features of the gut microbiome in an advanced intercross population of mice. Genome Biol. 15 (2014), 1–20.
115. [115] Goodrich, J.K., Davenport, E.R., Beaumont, M., Jackson, M.A., Knight, R., Ober, C., Spector, T.D., Bell, J.T., Clark, A.G., Ley, R.E., Genetic determinants of the gut microbiome in UK twins. Cell Host Microbe 19 (2016), 731–743.